Abstract:Object. Growth factors such as bone morphogenetic protein—2 (BMP-2) have been proven to promote spine fusion and to overcome the disadvantages of an autologous bone graft. The optimum method to deliver such growth factors remains a matter of discussion. The purpose of this study was to determine the safety and efficacy of a new poly(d,l-lactide) (PDLLA) carrier system for BMP-2 and to compare this carrier system with a collagen spo… Show more
“…32 Kandziora et al reported 0 of 8 solid fusions using tricortical iliac crest bone graft, 1 of 8 using Harm's titanium mesh cages, and 0 of 8 using titanium box cages in sheep cervical spines (C3-C4) after 12 weeks. 36 Similar results were reported from the same laboratory using absorbable polymercoated titanium cages, 33,37 and complete fusions could only be demonstrated with the use of growth factors. 37 This group also reported 0 of 8 solid fusions with tricortical iliac crest graft, 0 of 7 with an absorbable 70:30 poly(L-lactide:D,L-lactide) copolymer cage, and 6 of 8 with an absorbable polymer-calcium phosphatecomposite (PCC) cage all stabilized with titanium plates.…”
Using both absorbable and nonabsorbable implants, high fusion rates were achieved in the challenging sheep cervical spine model. However, the absorbable cages were not able to withstand the mechanical forces during the 6-month survival period.
“…32 Kandziora et al reported 0 of 8 solid fusions using tricortical iliac crest bone graft, 1 of 8 using Harm's titanium mesh cages, and 0 of 8 using titanium box cages in sheep cervical spines (C3-C4) after 12 weeks. 36 Similar results were reported from the same laboratory using absorbable polymercoated titanium cages, 33,37 and complete fusions could only be demonstrated with the use of growth factors. 37 This group also reported 0 of 8 solid fusions with tricortical iliac crest graft, 0 of 7 with an absorbable 70:30 poly(L-lactide:D,L-lactide) copolymer cage, and 6 of 8 with an absorbable polymer-calcium phosphatecomposite (PCC) cage all stabilized with titanium plates.…”
Using both absorbable and nonabsorbable implants, high fusion rates were achieved in the challenging sheep cervical spine model. However, the absorbable cages were not able to withstand the mechanical forces during the 6-month survival period.
“…A marked atrophy of the uterus has been used as evidence of the success of ovariectomy for estrogen directly affects uterine weight. 10 Indeed, ovariectomy resulted in a significant decrease in uterine weight. Ironically, 32KP did not exhibit any uterotrophic activity; this lack of uterotrophic activity could be beneficial in reducing the risk of diseases associated with E2 treatment.…”
“…19 The Food and Drug Administration has approved the use of a type-I collagen sponge enhanced with rhBMP-2 in combination with a tapered, threaded fusion cage (LT-CAGE; Medtronic Sofamor Danek) for the treatment of lumbar degenerative disc disease. 20 Although less attention has been focused on the use of rhBMP-2 in anterior cervical spine fusions, both animal [21][22][23] and human 24 studies have shown favorable outcomes. The primary feature was the ability of rhBMP-2 to enhance significantly the rate of fusion without associated adverse effects.…”
A significant rate of complications resulted after the use of a high dose of INFUSE in anterior cervical fusions. We hypothesize that in the cervical area, the putative inflammatory effect that contributes to the effectiveness of INFUSE in inducing fusion may spread to adjacent critical structures and lead to increased postoperative morbidity. A thorough investigation is warranted to determine the optimal dose of rhBMP-2 that will promote cervical fusion and minimize complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.